(Q34579440)

3 August 2017

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. (English)

1 reference

3 August 2017

1 reference

Robert B. Nussenblatt

6

object named as

Robert B Nussenblatt

1 reference

3 August 2017

Ahjoku Amadi-Obi

1

1 reference

3 August 2017

Cheng-Rong Yu

2

1 reference

3 August 2017

Xuebin Liu

3

1 reference

3 August 2017

Rashid M Mahdi

4

1 reference

3 August 2017

Grace Levy Clarke

5

1 reference

3 August 2017

Igal Gery

7

1 reference

3 August 2017

Yun Sang Lee

8

1 reference

3 August 2017

Charles E Egwuagu

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

13 May 2007

1 reference

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

711-718

1 reference

3 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1585

3 August 2017

0 references

cites work

STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice

1 reference

Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.

21 January 2018

1 reference

Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance

21 January 2018

1 reference

A role for IL-27 in early regulation of Th1 differentiation

21 January 2018

1 reference

IL-27 limits IL-2 production during Th1 differentiation.

21 January 2018

1 reference

Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism.

21 January 2018

1 reference

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

7 January 2021

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

1 reference

7 January 2021

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

1 reference

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

7 January 2021

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

7 January 2021

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

1 reference

7 January 2021

TGF-beta, a 'double agent' in the immune pathology war

1 reference

7 January 2021

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

7 January 2021

Bench to bedside: new approaches to the immunotherapy of uveitic disease

1 reference

7 January 2021

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

7 January 2021

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial

1 reference

7 January 2021

Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis

1 reference

7 January 2021

Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.

1 reference

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

7 January 2021

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

1 reference

7 January 2021

Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system

1 reference

7 January 2021

Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins.

1 reference

7 January 2021

IL-17 family cytokines and the expanding diversity of effector T cell lineages

1 reference

7 January 2021

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

1 reference

7 January 2021

Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.

1 reference

7 January 2021

Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27

1 reference

7 January 2021

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

1 reference

7 January 2021

Helper T cell differentiation enters a new era: le roi est mort; vive le roi!

1 reference

7 January 2021

IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.

1 reference

7 January 2021

Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations.

1 reference

7 January 2021

Cytokine profile in Behçet's disease patients. Relationship with disease activity

1 reference

7 January 2021

Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases

1 reference

7 January 2021

1 reference

7 January 2021

Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a

1 reference

7 January 2021

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study

1 reference

7 January 2021

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

1 reference

7 January 2021

SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1585

1 reference

3 August 2017

1 reference